Lorenzo D’Ambrosio
@lorenzodambrosio.bsky.social
📢📢 Hot off the press: trabectedin+olaparib vs trabectedin in advanced STS just published in Annals of Oncology‼️
⚠️Marginal benefit in all comers
🔬🧬Meaningful activity in uLMS and PARP1+ve STS.
An outstanding collaboration of 13 Italian Sarcoma Group centers!
www.annalsofoncology.org/article/S092...
⚠️Marginal benefit in all comers
🔬🧬Meaningful activity in uLMS and PARP1+ve STS.
An outstanding collaboration of 13 Italian Sarcoma Group centers!
www.annalsofoncology.org/article/S092...
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase 2 study from the Italian Sarcoma Group
Advanced/metastatic soft tissue sarcomas (STS) remain an unmet clinical need. We previously
reported the feasibility and preliminary activity of trabectedin-olaparib combination
in patients with advan...
www.annalsofoncology.org
December 11, 2025 at 9:17 PM
📢📢 Hot off the press: trabectedin+olaparib vs trabectedin in advanced STS just published in Annals of Oncology‼️
⚠️Marginal benefit in all comers
🔬🧬Meaningful activity in uLMS and PARP1+ve STS.
An outstanding collaboration of 13 Italian Sarcoma Group centers!
www.annalsofoncology.org/article/S092...
⚠️Marginal benefit in all comers
🔬🧬Meaningful activity in uLMS and PARP1+ve STS.
An outstanding collaboration of 13 Italian Sarcoma Group centers!
www.annalsofoncology.org/article/S092...
The @ItalianSarcomaGroup consensus paper on extended molecular profiling in mesenchymal tumors is out!
Huge thanks to everyone who contributed to this collaborative effort!
@merlini-ale.bsky.social
doi.org/10.1016/j.cr...
Huge thanks to everyone who contributed to this collaborative effort!
@merlini-ale.bsky.social
doi.org/10.1016/j.cr...
October 6, 2025 at 10:48 AM
The @ItalianSarcomaGroup consensus paper on extended molecular profiling in mesenchymal tumors is out!
Huge thanks to everyone who contributed to this collaborative effort!
@merlini-ale.bsky.social
doi.org/10.1016/j.cr...
Huge thanks to everyone who contributed to this collaborative effort!
@merlini-ale.bsky.social
doi.org/10.1016/j.cr...
What an amazing FORTRESS meeting!
Thanks @seppobauer.bsky.social, Julia and all the Essen team for having been such great hosts and thanks to all FORTRESSians for the wonderful exchange of projects and ideas!
Looking forward to future steps!
Thanks @seppobauer.bsky.social, Julia and all the Essen team for having been such great hosts and thanks to all FORTRESSians for the wonderful exchange of projects and ideas!
Looking forward to future steps!
February 14, 2025 at 6:28 PM
What an amazing FORTRESS meeting!
Thanks @seppobauer.bsky.social, Julia and all the Essen team for having been such great hosts and thanks to all FORTRESSians for the wonderful exchange of projects and ideas!
Looking forward to future steps!
Thanks @seppobauer.bsky.social, Julia and all the Essen team for having been such great hosts and thanks to all FORTRESSians for the wonderful exchange of projects and ideas!
Looking forward to future steps!
Reposted by Lorenzo D’Ambrosio
Just once more sleeping. And then its #fortressmeeting again. Team Essen is looking forward to a meeting full of ❤️💘🌹 and science. Both currently not much en vogue in some places. #fightforthecureofsarcomas
www.fortressmeeting.com
www.sarkomtour.de
www.fortressmeeting.com
www.sarkomtour.de
Home
FORTRESS2025 All information regarding the 5th edition of the Forum For Translational Research in Sarcomas in Essen Germany on Feb 13th&14th 2025
www.fortressmeeting.com
February 11, 2025 at 7:37 AM
Just once more sleeping. And then its #fortressmeeting again. Team Essen is looking forward to a meeting full of ❤️💘🌹 and science. Both currently not much en vogue in some places. #fightforthecureofsarcomas
www.fortressmeeting.com
www.sarkomtour.de
www.fortressmeeting.com
www.sarkomtour.de